Document Detail

Inflammatory myopathy in oculopharyngeal dystrophy.
MedLine Citation:
PMID:  545144     Owner:  NLM     Status:  MEDLINE    
A 75-year-old French-Canadian woman with familial oculopharyngeal dystrophy demonstrated histopathologic alterations similar to those of idiopathic polymyositis. A second biopsy obtained 15 months later was more consistent with previously reported cases. It is suggested that certain patients with oculopharyngeal dystrophy may pass through an initial phase of secondary muscle inflammation similar to that seen in some other heritable myopathies.
E P Bosch; J D Gowans; T Munsat
Related Documents :
17638164 - Hereditary sacrococcygeal teratoma--not the same as its sporadic counterpart!
9646204 - Juvenile polyposis coli and associated anomalies. review of the literature and report o...
8194554 - Familial testotoxicosis in a chinese family.
2892894 - Antiserum to scrapie-associated fibril protein reacts with amyloid plaques in familial ...
20537884 - Acute closed rupture of ehl revisited.
12860604 - National surveillance for the human ehrlichioses in the united states, 1997-2001, and p...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Muscle & nerve     Volume:  2     ISSN:  0148-639X     ISO Abbreviation:  Muscle Nerve     Publication Date:    1979 Jan-Feb
Date Detail:
Created Date:  1980-07-12     Completed Date:  1980-07-12     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7803146     Medline TA:  Muscle Nerve     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  73-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Deglutition Disorders / complications
Muscular Dystrophies / complications*,  genetics
Ophthalmoplegia / complications*,  genetics,  pathology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  F chronodispersion: a new electrophysiologic method.
Next Document:  Neurotrophic control of skeletal muscle phospholipids.